Monotherapy versus combination therapy for febrile neutropenia

International Journal of Hematology

Volumn 68, Issue SUPPL. 1, 1998, Pages

  Ramphal, Reuben ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBENICILLIN; CEFALOTIN; CEFEPIME; CEFTAZIDIME; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TOBRAMYCIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DRUG EFFICACY; FEVER; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION RISK; LEUKOCYTE COUNT; NEUTROPENIA; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; SURVIVAL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; FEVER; HUMANS; NEUTROPENIA;

EID: 0031795528     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Schimpff SC et al. Empiric Therapy with Carbonicillin and Gentamicin for Febrile Patients with Cancer and Granulocytopenia. N Engl J Med 1971;284:1061-1065.
2. Klastersky JA, Zinner SK. Synergistic Combinations of Antibiotics in Gram-Negative Bacillary Infections. Rev Infect Dis 1982;4:294-298.
3. de Jongh CA, Joshi JH, Newman KA et al. Antibiotic synergism and response in gram negative bacteremia in granulocytopenic patients. Am J Med 1986;80:(suppl 8C):96-111.
4. Pizzo PA et al. A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia. N Engl J Med 1986;315:552-558.
5. The EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidine Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with Granulocytopenia. N Engl J Med 1987;317:1692-1698.
6. De Paw BE et al. The Intercontinental Antimicrobial Study Group. Ceftazidime Compared with Piperacillin and Tobramycin for the Empiric Treatment of Fever in Neutropenic Patients with Cancer: A Multicenter Randomized Trial. Ann Intern Med 1994;120:834-844.
7. Carratala J et al. Bacteremia Due to Viridans Streptocci that are Highly Resistant to Penicillin: Increase Among Neutropenic Patients with Cancer. Clin Infect Dis 1995;20:1169-1173.
8. Rolston KVL et al. The Changing Spectrum of Bacterial Infections in Febrile Neutropenic Patients. In Klastersky JA (Ed): Febrile Neutropenia. Berlin Heidelberg: Springer-Verlag, 1997;53-56.
9. Mangein J et al. Activité in vitro de Six Beta Lactamines Vis-à-Vis de 295 Souches d'Enterobacteries et P. Aerruginosa Isolées Chez des Patients Neutropéniques. Pathologie Biologie 1995;43:253-257.
10. Johnson MP, Ramphal R. Beta-Lactam-Resistant Enterobacter Bacteremia in Febrile Neutropenic Patients Receiving Monotherapy. J Infect Dis 1990;162:981-983.
11. Breen J et al. Cefepime versus Ceftazidime as Empiric Therapy of Febrile Episodes in Neutropenic Patients. In Klastersky JA (Ed): Febrile Neutropenia. Berlin Heidelberg: Springer-Verlag, 1997;63-74.
12. Cometta A et al. Monotherapy with Meropenem versus Combination Therapy with Ceftazidime Plus Amikacin as Empiric Therapy for Fever in Granulocytopenic Patients with Cancer. Antimicrob Ag Chemother 1996;40:1108-1115.